123 related articles for article (PubMed ID: 27736810)
1. EGF receptor targeted lipo-oligocation polyplexes for antitumoral siRNA and miRNA delivery.
Müller K; Klein PM; Heissig P; Roidl A; Wagner E
Nanotechnology; 2016 Nov; 27(46):464001. PubMed ID: 27736810
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor targeted methotrexate and small interfering RNA co-delivery.
Steinborn B; Truebenbach I; Morys S; Lächelt U; Wagner E; Zhang W
J Gene Med; 2018 Jul; 20(7-8):e3041. PubMed ID: 29949222
[TBL] [Abstract][Full Text] [Related]
3. Double Click-Functionalized siRNA Polyplexes for Gene Silencing in Epidermal Growth Factor Receptor-Positive Tumor Cells.
Wang Y; Luo J; Truebenbach I; Reinhard S; Klein PM; Höhn M; Kern S; Morys S; Loy DM; Wagner E; Zhang W
ACS Biomater Sci Eng; 2020 Feb; 6(2):1074-1089. PubMed ID: 33464867
[TBL] [Abstract][Full Text] [Related]
4. Co-delivery of pretubulysin and siEG5 to EGFR overexpressing carcinoma cells.
Truebenbach I; Zhang W; Wang Y; Kern S; Höhn M; Reinhard S; Gorges J; Kazmaier U; Wagner E
Int J Pharm; 2019 Oct; 569():118570. PubMed ID: 31352048
[TBL] [Abstract][Full Text] [Related]
5. Post-PEGylation of siRNA Lipo-oligoamino Amide Polyplexes Using Tetra-glutamylated Folic Acid as Ligand for Receptor-Targeted Delivery.
Müller K; Kessel E; Klein PM; Höhn M; Wagner E
Mol Pharm; 2016 Jul; 13(7):2332-45. PubMed ID: 27177200
[TBL] [Abstract][Full Text] [Related]
6. Dual antitumoral potency of EG5 siRNA nanoplexes armed with cytotoxic bifunctional glutamyl-methotrexate targeting ligand.
Lee DJ; Kessel E; Edinger D; He D; Klein PM; Voith von Voithenberg L; Lamb DC; Lächelt U; Lehto T; Wagner E
Biomaterials; 2016 Jan; 77():98-110. PubMed ID: 26584350
[TBL] [Abstract][Full Text] [Related]
7. Targeted siRNA Delivery Using a Lipo-Oligoaminoamide Nanocore with an Influenza Peptide and Transferrin Shell.
Zhang W; Müller K; Kessel E; Reinhard S; He D; Klein PM; Höhn M; Rödl W; Kempter S; Wagner E
Adv Healthc Mater; 2016 Jun; 5(12):1493-504. PubMed ID: 27109317
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene.
Klutz K; Schaffert D; Willhauck MJ; Grünwald GK; Haase R; Wunderlich N; Zach C; Gildehaus FJ; Senekowitsch-Schmidtke R; Göke B; Wagner E; Ogris M; Spitzweg C
Mol Ther; 2011 Apr; 19(4):676-85. PubMed ID: 21245850
[TBL] [Abstract][Full Text] [Related]
9. Tumoral gene silencing by receptor-targeted combinatorial siRNA polyplexes.
Lee DJ; He D; Kessel E; Padari K; Kempter S; Lächelt U; Rädler JO; Pooga M; Wagner E
J Control Release; 2016 Dec; 244(Pt B):280-291. PubMed ID: 27287890
[TBL] [Abstract][Full Text] [Related]
10. EGFR Targeting and Shielding of pDNA Lipopolyplexes via Bivalent Attachment of a Sequence-Defined PEG Agent.
Morys S; Urnauer S; Spitzweg C; Wagner E
Macromol Biosci; 2018 Jan; 18(1):. PubMed ID: 28877405
[TBL] [Abstract][Full Text] [Related]
11. Gene silencing and antitumoral effects of Eg5 or Ran siRNA oligoaminoamide polyplexes.
Edinger D; Kläger R; Troiber C; Dohmen C; Wagner E
Drug Deliv Transl Res; 2014 Feb; 4(1):84-95. PubMed ID: 25786619
[TBL] [Abstract][Full Text] [Related]
12. Disconnecting the yin and yang relation of epidermal growth factor receptor (EGFR)-mediated delivery: a fully synthetic, EGFR-targeted gene transfer system avoiding receptor activation.
Schäfer A; Pahnke A; Schaffert D; van Weerden WM; de Ridder CM; Rödl W; Vetter A; Spitzweg C; Kraaij R; Wagner E; Ogris M
Hum Gene Ther; 2011 Dec; 22(12):1463-73. PubMed ID: 21644815
[TBL] [Abstract][Full Text] [Related]
13. EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo.
Fang Y; Yang W; Cheng L; Meng F; Zhang J; Zhong Z
Acta Biomater; 2017 Dec; 64():323-333. PubMed ID: 29030307
[TBL] [Abstract][Full Text] [Related]
14. Hydrophobic interactions between polymeric carrier and palmitic acid-conjugated siRNA improve PEGylated polyplex stability and enhance in vivo pharmacokinetics and tumor gene silencing.
Sarett SM; Werfel TA; Chandra I; Jackson MA; Kavanaugh TE; Hattaway ME; Giorgio TD; Duvall CL
Biomaterials; 2016 Aug; 97():122-32. PubMed ID: 27163624
[TBL] [Abstract][Full Text] [Related]
15. Systemic Delivery of Folate-PEG siRNA Lipopolyplexes with Enhanced Intracellular Stability for In Vivo Gene Silencing in Leukemia.
Lee DJ; Kessel E; Lehto T; Liu X; Yoshinaga N; Padari K; Chen YC; Kempter S; Uchida S; Rädler JO; Pooga M; Sheu MT; Kataoka K; Wagner E
Bioconjug Chem; 2017 Sep; 28(9):2393-2409. PubMed ID: 28772071
[TBL] [Abstract][Full Text] [Related]
16. Combinatorial siRNA Polyplexes for Receptor Targeting.
Lee DJ; Wagner E
Methods Mol Biol; 2019; 1974():83-98. PubMed ID: 31098997
[TBL] [Abstract][Full Text] [Related]
17. Structure-based peptide ligand design for improved epidermal growth factor receptor targeted gene delivery.
Decker S; Taschauer A; Geppl E; Pirhofer V; Schauer M; Pöschl S; Kopp F; Richter L; Ecker GF; Sami H; Ogris M
Eur J Pharm Biopharm; 2022 Jul; 176():211-221. PubMed ID: 35584718
[TBL] [Abstract][Full Text] [Related]
18. PolyIC GE11 polyplex inhibits EGFR-overexpressing tumors.
Abourbeh G; Shir A; Mishani E; Ogris M; Rödl W; Wagner E; Levitzki A
IUBMB Life; 2012 Apr; 64(4):324-30. PubMed ID: 22362419
[TBL] [Abstract][Full Text] [Related]
19. Nanosized multifunctional polyplexes for receptor-mediated siRNA delivery.
Dohmen C; Edinger D; Fröhlich T; Schreiner L; Lächelt U; Troiber C; Rädler J; Hadwiger P; Vornlocher HP; Wagner E
ACS Nano; 2012 Jun; 6(6):5198-208. PubMed ID: 22646997
[TBL] [Abstract][Full Text] [Related]
20. Particle-Size-Dependent Delivery of Antitumoral miRNA Using Targeted Mesoporous Silica Nanoparticles.
Haddick L; Zhang W; Reinhard S; Möller K; Engelke H; Wagner E; Bein T
Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32498278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
